文献速递乳房整形与再造显微修复重建

肿瘤整形技术预准备:保留乳头乳房切除与自体乳房重建中控制乳房包膜

Oncoplastic Procedures in Preparation for Nipple-Sparing Mastectomy and Autologous Breast Reconstruction: Controlling the Breast Envelope.
PubMed 文献 · Plast Reconstr Surg · 2020-01-01

结果显示部分乳头乳晕复合体坏死8.2%、完全坏死6.6%、移位1.6%、皮瓣皮肤坏死6.6%,无皮瓣丢失,提示分期方案可安全扩展保留乳头的适应证。

要点

  • 分期法可安全用于中度至重度下垂和/或巨乳症患者的保留乳头乳房切除与自体重建
  • 二期术后部分乳头乳晕复合体坏死发生率8.2%、完全坏死6.6%
  • 皮瓣皮肤坏死6.6%,无皮瓣丢失,乳头乳晕复合体移位1.6%

核心结论

  • 对于中度至重度乳房下垂和/或巨乳症且希望接受乳房切除与重建的患者,实施分期方案可安全提供保留乳头的术式。

主要发现

  • 二期术后部分乳头乳晕复合体坏死5例(8.2%),完全坏死4例(6.6%),乳头乳晕复合体移位1例(1.6%),乳房切除皮瓣皮肤坏死4例(6.6%),本系列无皮瓣丢失。
  • 一期与二期平均间隔16.9周(范围3至31周),所有浸润性癌及原位病变在一期后均获得切缘阴性。

临床怎么用

  • 对中度至重度乳房下垂和/或巨乳症患者,可考虑先行双侧肿瘤整形缩乳/乳房固定,再行保留乳头乳房切除与自体皮瓣重建的分期方案。

局限性

  • 本研究为回顾性分析,证据等级为治疗性IV级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nipple-sparing mastectomy has been associated with superior aesthetic outcomes and oncologic safety. However, traditional contraindications, such as breast ptosis/macromastia, have excluded a large number of patients. The purpose of this study was to determine whether a staged approach would expand the indications for nipple-areolar complex preservation and permit greater control over nipple-areolar complex position and skin envelope following autologous reconstruction. METHODS: A retrospective analysis was conducted of female patients with a diagnosis of breast cancer or BRCA mutation with grade 2 or 3 ptosis and/or macromastia who underwent bilateral (oncoplastic) reduction/mastopexy (stage 1) followed by bilateral nipple-sparing mastectomy with immediate reconstruction with free abdominal flaps (stage 2). The authors were specifically interested in the incidence of mastectomy skin necrosis and nipple-areolar complex necrosis and malposition following stage 2. RESULTS: Sixty-one patients with a mean age of 45.1 years (range, 28 to 62 years) and mean body mass index of 32.6 kg/m (range, 23.4 to 49.0 kg/m) underwent reconstruction with 122 flaps. The mean interval between stage 1 and 2 was 16.9 weeks (range, 3 to 31 weeks). Clear margins were obtained in all cases of invasive cancer and in situ disease following stage 1. Complications following stage 2 included partial nipple-areolar complex necrosis (n = 5, 8.2 percent), complete nipple-areolar complex necrosis (n = 4, 6.6 percent), nipple-areolar complex malposition (n = 1, 1.6 percent), and mastectomy skin necrosis (n = 4, 6.6 percent). No flap loss was noted in this series. CONCLUSION: Patients with moderate to severe breast ptosis and/or macromastia who wish to undergo mastectomy with reconstruction can be offered nipple-sparing approaches safely if a staged algorithm is implemented. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Momeni A, Kanchwala S, Sbitany H, et al. Oncoplastic Procedures in Preparation for Nipple-Sparing Mastectomy and Autologous Breast Reconstruction: Controlling the Breast Envelope. Plast Reconstr Surg. 2020. PMID: 32221203. doi:10.1097/PRS.0000000000006657

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。